Hépato-Gastro & Oncologie Digestive
Agenda
Volume 31, issue 5, May 2024
ÉDITORIAL
What role do 5-aminosalicylates (5-ASAs) play in the treatment of IBD in the era of biotherapies and small molecules?
(p.435-7)
Xavier Roblin, Mathilde Barrau
Free Access
MINI-REVUES
MGMT status as a decision-making aid for chemotherapy in neuroendocrine tumors
(p.438-44)
Alice Durand, Thomas Walter
Vaccination against human papillomavirus: which place in proctology in 2024?
(p.445-50)
Déborah Roland, Mélanie Draullette, Sébastien Fouéré, Vincent de Parades
How should chronic liver disease of undetermined aetiology be investigated?
(p.451-8)
Anna Sessa, Vincent Leroy
Chronic anorectal and pelvic pain: state of the art
(p.459-63)
Axel Egal, Nabila Rabahi, Saliha Ysmail Dahlouk, Patrick Atienza, Isabelle Etienney
Anorectal manometry contributions in chronic anorectal pain
(p.464-72)
Axel Egal, Nabila Rabahi, Saliha Ysmail Dahlouk, Patrick Atienza, Isabelle Etienney
Remote training in digestive endoscopy: myth or reality?
(p.473-9)
Mohamed Tayeb Bounnah, Gabriel Rahmi
Dossier thématique : Rectites
Pre-test
(p.481-2)
Amélie Barré
Mise au point
Proctitis
(p.483-94)
Amélie Barré, Nadia Fathallah, Marie Lazareth, Déborah Roland, Amine Alam, Élise Pommaret, Anne-Laure Rentien, Vincent Parades de
Cas clinique
Traps of rectitis
(p.495-8)
Élise Pommaret, Amélie Barré, Vincent Parades de
Revue bibliographique
The wide range of proctitis
(p.499-505)
Philippe Marteau
Entretien avec l'expert
Chronic inflammatory proctitis
(p.506-8)
Philippe Seksik
Post-test
(p.509-10)
Amélie Barré
CONCEPTS ET PRATIQUE
New guidelines for IPMN diagnosis and surveillance: what is really changing?
(p.511-6)
Lina Aguilera Munoz, Christelle d’Engremont
EUS-guided gastroenterostomy: the end of the duodenal stent?
(p.517-23)
Rémi Collin, Thomas Guilmoteau, Jérémie Jacques
Gene therapy of Crigler-Najjar syndrome: a first in the field of hepatology!
(p.524-7)
Alexandre Pariente
The therapeutic options increase with the arrival of fruquintinib in refractory metastatic colorectal cancer
(p.528-32)
David Sefrioui
Treating the cause amitriptyline as second-line treatment for irritable bowel syndrome
(p.533-8)
Zlata Chkolnaia, Mathieu Uzzan
BRÈVE D’HISTOIRE
Imperial haemorrhoidal thrombosis: the hidden face of a resounding defeat...
(p.539-41)
Vincent Parades de, Nadia Fathallah
INJECTIONS DE RAPPEL
À retenir du n°4 Avril 2024
(p.542-4)